Interventional oncology is rapidly evolving - are you keeping up? Stay current by viewing the most comprehensive educational opportunity dedicated to initiating, developing, or strengthening your practice in the Y-90 treatment of hepatic malignancies.

SIR delivers the premier and unique learning opportunity dedicated to Y-90 education - Y-90: The Complete Course. Ideal for those seeking AU status through those who are already experienced practitioners, all relevant course components have been streamlined and combined with advanced case discussion presented by expert faculty. Y-90: The Complete Course’s curriculum is the most comprehensive and challenging radioembolization learning experience available to interventional radiologists and trainees.

Learning Objectives

Upon completion of this course, the attendee should be able to:

• Discuss the current algorithms and outcomes for treatment of primary and secondary hepatic malignancies inclusive of surgical, medical and transarterial therapies and explore the ideal sequencing of radioembolization in those algorithms.
• Describe advanced radioembolization techniques.
• Describe best practice in Y-90 radiation safety and dose management.
• Describe advanced radiation physics and various methods of calculation of dosimetry and how they vary between available platforms.
• Explain advanced dosimetry and treatment concepts.
• Identify therapies used in combination with radioembolization for hepatic malignancy.
• Summarize a state-of-the-art literature review of Y-90 radioembolization.

Accreditation Statement
The Society of Interventional Radiology (SIR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide medical education for physicians.

SIR designates this enduring material for a maximum of 16.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is approved for 16.00  by the Society of Interventional Radiology (SIR). SIR is awarded Deemed Status by the American Board of Radiology (ABR).